Anbio Biotechnology (NNNN) Receivables - Other (2025)

Anbio Biotechnology (NNNN) recorded quarterly Receivables - Other of $948.0 in Q4 2025.

Anbio Biotechnology (NNNN) Receivables - Other (2025) Analysis & Trends

Anbio Biotechnology's Receivables - Other history runs 1 years deep, the most recent figure standing at $948.0 for Q4 2025.

In Q4 2025, Receivables - Other changed N/A year-over-year to $948.0; the TTM figure through Dec 2025 stood at $948.0 (changed N/A YoY), while the FY2025 annual figure was $948.0, changed N/A from the prior year.
Receivables - Other was $948.0 for Q4 2025 at Anbio Biotechnology.
In the past five years, Receivables - Other ranged from a high of $948.0 in Q4 2025 to a low of $948.0 in Q4 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn
10	Anbio Biotechnology	720.59 Mn	708.69 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2025	948.00
Dec 31, 2025	948.00